Searched for
TAKEDA PHARMACEUTICAL COMPANY
Takeda to launch dengue vaccine in India next yearTakeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentThe Innovation Capability Centre plans to hire 750 professionals, including software engineers, data scientists, and cybersecurity experts,...
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentTakeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, and cybersecurit...
- Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian marketLupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The ...
- Alkem inks licensing pact with Takeda to introduce Vonoprazan in IndiaAlkem Laboratories has entered into a patent licensing agreement with Takeda Pharmaceutical to market Vonoprazan in India. This medication ...
- Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drugNew Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...
- Zydus inks licensing pact with Takeda to sell GERD drug"With a rich legacy in marketing gastrointestinal therapies in India, we have been offering different breakthrough clinical options across ...
- Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in IndiaSun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...
- Takeda to soon start trials in India for dengue vaccineTakeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...
- Indian-origin data analyst killed after struck by bus at Boston airportVishwachand Kolla, a data analyst at the Takeda Pharmaceutical Company and an Indian-American, died in a fatal bus accident at Boston's Log...
- Takeda in talks to bring its dengue shot to IndiaIndia is not a part of the global Phase-3 trial of the Takeda dengue vaccine candidate, which means as per local regulation it will have to...
- Chief of Asia's largest pharmaceutical company urges transparency in virus vaccine rolloutTakeda, one of the world's biggest pharmaceutical companies, is not developing its own vaccine but has contracts with several firms to dist...
- Zydus Cadila partners Takeda for chikungunya vaccineCadila Healthcare said terms of the agreement are not disclosed, but it is expected that this partnership will boost access to medicines in...
- Alembic Pharma gets tentative nod from USFDA for FebuxostatThe product is therapeutic equivalent to the reference listed drug Uloric tablets, 40 mg, 80 mg of Takeda Pharmaceuticals USA Inc, it added.
- Rashmi Barbhaiya, co-founder of Advinus Therapeutics resigns from the post of managing directorRashmi Barbhaiya, who co-founded Tata group-promoted pharmaceutical research company Advinus Therapeutics, has stepped down from the post o...
- Dr Reddy’s Laboratories slips as Sucampo files lawsuitDr Reddy’s Laboratories were down on profit booking in early trade after Sucampo Pharmaceuticals and others filed patent infringement lawsu...
- Sun Pharmaceuticals files ANDAs for 4 products in Q1 FY14Sun Pharmaceutical Industries filed Abbreviated New Drug Applications for 4 products & received 9 approvals from USFDA in Q1 this fiscal.
- Sun Pharma arm to buy Takeda's US-based generics subsidiary URL PharmaSun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning tradeShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
- Japan's Takeda in $8.8 billion bid for US biotech firmJapan's Takeda Pharmaceutical Co has agreed to pay about $8.8 billion for US biotech company Millennium Pharmaceuticals Inc, the two firms ...
Load More
